Low frequency of CYP2A6 gene polymorphism as revealed by a one-step polymerase chain reaction method

Pharmacogenetics

Volumn 9, Issue 3, 1999, Pages 327-332

  Chen, Gen Fu ^a   Tang, Yong Ming ^a   Green, Bridgett ^a   Lin, Dong Xin ^b   Guengerich, F Peter ^c   Daly, Ann K ^d   Caporaso, Neil E ^e   Kadlubar, Fred F ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cytochrome P450; DNA sequencing; Genetic polymorphism restriction fragment length polymorphism

Indexed keywords

CYTOCHROME P450; RESTRICTION ENDONUCLEASE;

ALLELE; ARTICLE; CAUCASIAN; CHINESE; DNA POLYMORPHISM; EXON; GENE FREQUENCY; HUMAN; JAPAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RACE DIFFERENCE;

EID: 0032805514     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199906000-00007     Document Type: Article

References (17)

1. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 1976; 3:2303-2308.
2. Crespi CL, Penman BW, Gelboin HV, Gonzalez FJ. A tobacco smoke-denied nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P450206. Carcinogenesis 1991; 12: 1197-1201.
3. Ding X, Coon MJ. Purification and characterization of two unique forms of cytochrome P-450 from rabbit nasal microsomes. Biochemistry 1988; 29:1322-1329.
4. Fernandez-Salguero P, Hoffman SMG, Cholerton S, Mohrenweiser H, Raunio H, Rautio A, et al. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am J Hum Genet 1995; 57:651-660.
5. Gullstén H, Agúndez JAG, Benítez J, Läärä E, Ladero JM, Díaz-Rubio M, et al. CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis. Pharmacogenetics 1997; 7:247-250.
6. Hadidi H, Zahlsen K, Idle JR, Cholerton S. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin. Food Chem Toxicol 1997; 35:903-907.
7. Kaltenbock B, Schneider R. Differential amplification kinetics for point mutation analysis by PCR. BioTechniques 1998; 24:202-206.
8. Messina ES, Tyndale RF, Sellers EM. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997; 282:1608-1614.
9. Miles JS, McLaren AW, Forrester LM, Glancey MJ, Lang MA, Wolf CR. Identification of the human liver cytochrome P-450 responsible for coumarin 7-hydroxylase activity. Biochem J 1990; 267:365-371.
10. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 1996; 6:1-42.
11. Nunoya K-I, Yokoi T, Kimura K, Inoue K, Kodama T, Funayama M, et al. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3, 5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502). Pharmacogenetics 1998; 8:239-249.
12. Oscarson M, Gullstén H, Rautio A, Bernal ML, Sinues B, Dahl M-L, et al. Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C-oxidase. FEBS Lett 1998; 438:201-205.
13. Tiano HF, Wang R-L, Hosokawa M, Crepsi C, Tindal KR, Langenbach R. Human CYP2A6 activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK): mutational specificity in the gpt gene of AS52 cells. Carcinogenesis 1994; 15:2859-2866.
14. Yamano S, Tatsuno J, Gonzalez FJ. The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in liver microsomes. Biochemistry 1990; 29:1322-1329.
15. Yamazaki H, Inui Y, Yun C-H, Guengerich FP, Shimada T. Cytochrome P450 2EJ and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes. Carcinogenesis 1992; 13:1789-1794.
16. Yokoi T, Kamataki T. Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese. Pharmaceutical Res 1998; 15:517-524.
17. Yun CH, Shimada T, Guengerich FP. Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol 1991; 40:679-685.